Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration ...

Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral ...

Zydus Lifesciences Ltd has been implicated in a recall of 23,304 bottles of Dapsone Gel 7.5%, a popular acne treatment ...

Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...

The FDA has recalled 23,304 bottles of Dapsone Gel 7.5%, an acne treatment, due to crystallization that can impact dosage and ...

The Pharma sector outperformed in 2024, gaining 29%, driven by resilience to macro challenges, US FDA resolutions, and ...

Zydus' expanding product pipeline and strong fundamentals make it a compelling play in the pharmaceutical sector, the brokerage said.

Zydus Pharmaceuticals USA Inc President & CEO ... set the way for further strengthening our portfolio of differentiated products in the US market”, he added. CVS Caremark is one of the most ...

Bayer Zydus Pharma Private Limited. Established on 28th January 2011 as a 50:50 partnership to market and sell pharmaceutical products in India, Bayer will now take full ownership of the entity as ...